BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Intellia Therapeutics

Intellia Therapeutics logo

Founded
2014
Patents
39
Clinical Trials
3
Publications
16

Technologies

CRISPR Startups Gene Therapy Startups

Intellia is a leading genome editing company focused on the development of proprietary, potentially curative therapeutics utilizing a recently developed biological tool known as the CRISPR/Cas9 system. We believe that the CRISPR/Cas9 technology has the potential to transform medicine by permanently editing diseased genes in the human body through a single treatment course. We intend to leverage our leading scientific expertise, clinical development experience and intellectual property position to unlock broad therapeutic applications of CRISPR/Cas9 genome editing and develop a potential new drug class.

Become a Member to view additional information about this company

Posts Mentioning This Company

Biopharma Insights